×
ADVERTISEMENT

APRIL 20, 2016

Federally Funded Cancer Trials: Is the Public Receiving an Acceptable ROI?

Maurie Markman, MD
Cancer Treatment Centers of America
Drexel University College of Medicine
Philadelphia, Pennsylvania

The benefits to the public associated with support of cancer research, in general, and clinical cancer research, in particular, are well recognized. From the demonstration of the absence of utility of radical surgery compared with a far less-aggressive approach in the management of breast cancer to the trial-based evidence of the survival effect of paclitaxel in advanced ovarian